Overview

HKT-500 in the Treatment of Adult Patients With Ankle Sprain

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to demonstrate the multiple-dose efficacy and safety of HKT-500 for the treatment of ankle sprain.
Phase:
Phase 3
Details
Lead Sponsor:
Hisamitsu Pharmaceutical Co., Inc.
Treatments:
Ketoprofen